ARCHIVES

Advisors say NCI needs to reach out to other fields.

This article is from The Cancer Letter archive.

Vol. 31 No. 28 | July 15, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

In Brief: Yarbros To Move Frm Missouri To Illinois; Canellos Elected Fellow Of Royal College

February 21, 1992

Zaltrap Shows Improvement in Survival In Stage IV Metastatic Colorectal Cancer

July 29, 2011

Bevacizumab Improves PFS In Advanced Kidney Cancer

July 27, 2007

New Concepts Being Developed By Organ Systems Groups Described

January 2, 1987